The Story Of Our Firm | En Español
FONT SIZE: A A A A A

Drugs & Medical Devices

Advanced Bionics

in this section: Our Press Release | Research Center | FREE Legal Review | Questionnaire


Bookmark This Page Print This Page Email This Page

Weitz & Luxenberg Informs the Public of Potentially Defective Advanced Bionics Cochlear Implants


Get a Free Legal Assessment of Your Potential Case When You Complete the Form Below.

NEWS UPDATE: Weitz & Luxenberg P.C. would like to inform the public that Advanced Bionics LLC, a California-based manufacturer of cochlear implants, will pay the Food and Drug Administration (FDA) $1.1 million, and the company’s CEO Jeffrey Greiner will pay $75,000, as part of a settlement agreement regarding alleged violations of federal law.

The cochlear implant maker denies it violated federal law and has not conceded to any admission of liability in the settlement agreement.

The FDA has agreed not to initiate any administrative action or refer to the Department of Justice any criminal or civil action against Advanced Bionics arising from the manufacture and distribution of the HiRes90k cochlear implant that was known to the FDA on or before November 2, 2007.

However, the Settlement Agreement is binding on the FDA only, and does not preclude any action by any other agency or governmental entity, nor does it preclude the FDA from taking any other action based on information unknown to the FDA at the time of settlement or from using the evidence described in the Second Amended Complaint in support of further actions based on additional or later conduct.

Below is earlier information regarding the the FDA's decision to seek a penalty against Advanced Bionics LLC:

The U.S. Food and Drug Administration (FDA) is seeking a $2.2 million penalty against Advanced Bionics, the California manufacturer of cochlear implants.

Certain of the company's HiRes90K cochlear implants, according to the FDA website, may "pose a public health risk due to excessive moisture, exposing patients to the risk of device failure, possible surgery, and the potential for additional hearing loss."

According to the FDA's revised April 8, 2008 FDA News Release, "the complaint alleges that the company failed to comply with the FDA's current Good Manufacturing Practice (GMP) requirements for devices. GMP requires that companies manufacturing medical devices for sale in the United States establish and follow quality systems procedures to assure the safety and quality of their products."

The FDA's revised News Release also states that the "alleged GMP violations include the failure to sufficiently evaluate and select a new vendor as the supplier of a critical device component and the failure to adequately validate the continued safety and effectiveness of the cochlear implant by testing lots under actual or simulated use when the unapproved vendor's component was used...[and] that Advanced Bionics shipped cochlear implants in violation of the law between January 2005 and July 2006. Two cochlear implants shipped and implanted after a March 2006 recall contained the component from the unapproved vendor."

If you were a recipient of an Advanced Bionics HiRes90k Cochlear Implant, and have suffered physical or emotional injuries due to a malfunctioning implant, please complete the form below. A representative from our firm will contact you as soon as possible.

For more information:

View the Amended FDA Complaint and the FDA's updated News Release.

Click To Talk To Us Online

Please complete the following questionnaire:

Email:
Date Device Was Implanted:
Has your implant or related components failed to work properly?
Please Describe Any Problems or Injuries Caused by the Device:
Has your defective implant device been removed and if so when?
How did you find Weitz & Luxenberg? (Internet search, friend who found our website and became a client, referral)
Name:
Phone (optional):


see also:

Our Press Release Some Advanced Bionics Cochlear Implants a Health Risk--Lawsuit Info
Lawsuit info: Some people may have Cochlear Implants that have failed

FREE Legal Review Free Lawsuit Evaluation from Advanced Bionics Attorneys--ASL
Advanced Bionics Attorneys Offer Free Legal Review--Fluent in ASL

Trasylol Numerous Injuries Prompt Trasylol Lawsuits. FDA Halts Sales of Drug
Seeking compensation for your Trasylol injury? Get Free Lawsuit Info
Free Legal Review
Name:
Phone:
Email:
Case Description:
$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$25 million verdict —for New York City brake reliner who lost his right lung to mesothelioma

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.